Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3
about
Interaction of soluble CD163 with activated T lymphocytes involves its association with non-muscle myosin heavy chain type AHigh serum sCD163/sTWEAK ratio is associated with lower risk of digital ulcers but more severe skin disease in patients with systemic sclerosis.Differential expression of CD163 on monocyte subsets in healthy and HIV-1 infected individuals.The clinical significance of the CD163+ and CD68+ macrophages in patients with hepatocellular carcinoma.BANK1 and BLK act through phospholipase C gamma 2 in B-cell signalingSoluble CD163, a product of monocyte/macrophage activation, is inversely associated with haemoglobin levels in placental malaria.Elevated levels of monocyte activation markers are associated with subclinical atherosclerosis in men with and those without HIV infectionSoluble macrophage biomarkers indicate inflammatory phenotypes in patients with knee osteoarthritisAssociation between the haptoglobin and heme oxygenase 1 genetic profiles and soluble CD163 in susceptibility to and severity of human malaria.Thematic review series: the immune system and atherogenesis. Recent insights into the biology of macrophage scavenger receptors.Evaluation of serum sTWEAK and sCD163 levels in patients with acute and chronic coronary artery disease.Investigation of human cationic antimicrobial protein-18 (hCAP-18), lactoferrin and CD163 as potential biomarkers for ovarian cancerIncreased CD163 expression is associated with acute-on-chronic hepatitis B liver failure.CD163 and inflammation: biological, diagnostic, and therapeutic aspects.Soluble TWEAK may predict carotid atherosclerosis in treated HIV infection.Elevated levels of CXCL10 in the Periodic Fever, Aphthous stomatitis, Pharyngitis and cervical Adenitis syndrome (PFAPA) during and between febrile episodes; an indication of a persistent activation of the innate immune system.Serum levels of the soluble haemoglobin scavenger receptor CD163 in MPO-ANCA-associated renal vasculitis.Levels of soluble CD163 and severity of malaria in children in Ghana.Can soluble CD163 predict outcome of patients with acute respiratory distress from mechanical ventilation?: A pilot study.Serum sCD163 as a biomarker of adipose tissue inflammation in obstructive sleep apnoea patients: limits and perspectives.Tumor necrosis factor α-converting enzyme (TACE/ADAM17) mediates ectodomain shedding of the scavenger receptor CD163.Tissue inhibitor of metalloproteinases-3 and matrix metalloproteinase-3 regulate neuronal sensitivity to doxorubicin-induced apoptosis.Proteomic changes in cerebrospinal fluid from primary central nervous system lymphoma patients are associated with protein ectodomain shedding.Association of CD163+ macrophages and local production of soluble CD163 with decreased lymphocyte activation in spondylarthropathy synovitis.Increased levels of soluble CD163 in periodontitis patients.Interleukin-18 Amplifies Macrophage Polarization and Morphological Alteration, Leading to Excessive Angiogenesis.In vitro and in vivo evidence for the role of elastase shedding of CD163 in human atherothrombosis
P2860
Q24306764-74A0F9E7-1D86-4BC0-A5D6-1CB56CCD0FFAQ33765551-5D1D678C-AB8F-4D98-B21C-88DC7599B6FDQ33916381-40C03372-21EC-476F-ABD0-374BC4E8FE54Q34652179-ABCFF76E-BF98-4B0E-9B94-0282E627BF88Q34652368-61F2D208-AE38-4FA0-A8E7-5C167A642913Q34745250-08C2C18C-CD37-45D2-BC07-F476E28BE06CQ35473503-1EBDF5BD-C267-4705-A6DF-EDCA0E8EFBE7Q35635607-E4C39DEF-B881-4B2D-846D-9329023C2DF1Q35867634-E4AB0506-165D-4BB2-9820-65AD511AAB88Q35952837-6E16236C-70A7-476D-B1F3-EFB53BC70B5DQ35958888-F7DCAA71-53DA-47BF-8A61-FD1581C2A948Q36568222-B38A927D-92F9-49E3-841A-B7FC7E6EC3A6Q36841343-7B2F3159-06E9-4824-B16B-8A2B38B9DCFCQ38035395-9C0804B3-30E7-446F-BAA6-FBDE291985A4Q38614592-B2C325BA-5DEE-4E48-8421-16CD2BD3C639Q40231200-C355FC00-A4FA-4E98-8B85-A90CB3617E96Q40707608-1B68D1B3-4CFA-4305-ABDE-736BDAF7E489Q41833572-5F82823D-0605-4D1A-B9AC-08B3CC0FAFFFQ41892192-BDF65D3C-493C-472A-B087-582DFE32BACCQ42748068-7E2BFAA3-77CD-4CF8-8B0E-49C3D137E6D8Q42921094-0B5A0F81-2969-4D87-A090-547EED8B415DQ44574077-E78118A6-B690-4AFC-A7F4-01D57D8BDE62Q47151942-36231E54-8AA9-460C-8B38-FC6BD22111F1Q47596781-07DCA529-0311-4A33-96B6-0DF6584A6412Q48264104-BC438998-E125-4B13-BC57-122DFBFC1B2BQ55340253-56441CB0-6797-4B2E-9E22-024BE8818875Q57243353-56C13D0D-0C47-412F-AABE-D2EDBE711C91
P2860
Elevated levels of soluble CD163 in sera and fluids from rheumatoid arthritis patients and inhibition of the shedding of CD163 by TIMP-3
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@ast
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@en
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@nl
type
label
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@ast
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@en
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@nl
prefLabel
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@ast
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@en
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@nl
P2093
P2860
P1476
Elevated levels of soluble CD1 ...... he shedding of CD163 by TIMP-3
@en
P2093
M Kashiwagi
M Nakamura
N Matsushita
R Nagayoshi
T Matsuyama
P2860
P304
P356
10.1046/J.1365-2249.2002.01963.X
P407
P577
2002-10-01T00:00:00Z